Sponsors

Launch of pan-malaria monoclonal antibodies

ViroStat has released new parasitic lactate dehydrogenase (pLDH) monoclonal antibodies, which can be powerful immunoassay tools for malaria detection.

These monoclonal antibodies are reactive with Plasmodium falciparum, P. malariae and P. vivax. One pair of these antibodies can detect pLDH from all three species by enzyme-linked immunosorbent assay (ELISA).

Malaria can be caused by several species of the Plasmodium parasite. Parasitic lactate dehydrogenase is found in many Plasmodium species, and levels of this intracellular enzyme are elevated during the blood-stage of infection. Detection of this enzyme in blood is a strong indicator of malaria infection.

The data sheet for these new antibodies can be downloaded from the ViroStat website.

www.virostat-inc.com

Latest Issues

POCT Innovators: Power to Disrupt - Clinical Diagnostics Now

Leonardo Royal Hotel, Oxford
16 November, 2025

DIA-MHRA Global Summit

Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026

UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026

The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026

UK NEQAS webinar: Epigenetics

Online
1 December, 2026

UK NEQAS webinar: Fresh Muscle Biopsies

Online
8 December, 2026